The estimated Net Worth of Jeffrey M Nugent is at least 3.89 百万$ dollars as of 18 February 2020. Mr. Nugent owns over 133,576 units of Sientra Inc stock worth over 35,670$ and over the last 10 years he sold SIEN stock worth over 838,220$. In addition, he makes 3,015,280$ as Chairman of the Board、 Chief Executive Officer at Sientra Inc.
Sign up
Mr. Nugent SIEN stock SEC Form 4 insiders trading
Jeffrey has made over 5 trades of the Sientra Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 133,576 units of SIEN stock worth 792,106$ on 18 February 2020.
The largest trade he's ever made was selling 133,576 units of Sientra Inc stock on 18 February 2020 worth over 792,106$. On average, Jeffrey trades about 9,193 units every 81 days since 2014. As of 18 February 2020 he still owns at least 209,826 units of Sientra Inc stock.
You can see the complete history of Mr. Nugent stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeffrey Nugent biography
Jeffrey M. Nugent serves as Chairman of the Board, Chief Executive Officer of the Company. He has served as the Chairman of our Board and Chief Executive Officer since November 12, 2015 and a director of the Company since July 2014. Mr. Nugent was the Interim Chief Executive Officer of Biolase, Inc. from June 2014 to July 2015, in which he established a global commercialization team and chose new leaders of the sales and marketing division. Prior to that, from December 2010 to February 2013, Mr. Nugent was Founder, President and Chief Executive Officer of Precision Dermatology, Inc., a multi-channel skin care company that was acquired by Valeant Pharmaceuticals in February 2014. From 1999 to 2002, he served as the President and Chief Executive Officer of Revlon, Inc., where he led a turnaround in profitability and a global initiative of new product innovation. Prior to that, he was as Worldwide President and Chief Executive Officer of Neutrogena Corporation from 1995 to 1999 in which he led the acquisition by Johnson & Johnson. Mr. Nugent has previously served as a director of Neothetics, Inc., Precision Dermatology, Inc., Myoscience, Inc. and Bioform, Inc. (prior to its acquisition by Merz Aesthetics, Inc.) Mr. Nugent began his career at Johnson & Johnson where he held increasingly senior responsibilities in Manufacturing, Finance, Research and Development, Marketing and Worldwide Vice President for Quality. Mr. Nugent holds a B.S. in mathematics from St. Joseph’s College and earned his MBA in finance and marketing from Loyola University in Chicago. He served as an Artillery Officer in the United States Army.
What is the salary of Jeffrey Nugent?
As the Chairman of the Board、 Chief Executive Officer of Sientra Inc, the total compensation of Jeffrey Nugent at Sientra Inc is 3,015,280$. There are no executives at Sientra Inc getting paid more.
How old is Jeffrey Nugent?
Jeffrey Nugent is 72, he's been the Chairman of the Board、 Chief Executive Officer of Sientra Inc since 2015. There are no older and 7 younger executives at Sientra Inc.
What's Jeffrey Nugent's mailing address?
Jeffrey's mailing address filed with the SEC is 420 SOUTH FAIRVIEW AVENUE, SUITE 200, , SANTA BARBARA, CA, 93117.
Insiders trading at Sientra Inc
Over the last 10 years, insiders at Sientra Inc have traded over 15,843,498$ worth of Sientra Inc stock and bought 1,651,210 units worth 23,354,020$ . The most active insiders traders include Llp Abingworth、Advisors Llc Orbi Med Capit...、Timothy Haines. On average, Sientra Inc executives and independent directors trade stock every 73 days with the average trade being worth of 17,193$. The most recent stock trade was executed by Ronald Menezes on 10 November 2021, trading 78,498 units of SIEN stock currently worth 445,084$.
What does Sientra Inc's logo look like?
Complete history of Mr. Nugent stock trades at Biolase Inc、Sientra Inc
Sientra Inc executives and stock owners
Sientra Inc executives and other stock owners filed with the SEC include:
-
Jeffrey Nugent,
Chairman of the Board, Chief Executive Officer -
Paul Little,
Chief Financial Officer, Senior Vice President, Treasurer -
Keith Sullivan,
Director -
Mary Fisher,
Independent Director -
Philippe Schaison,
Independent Director -
Nicholas Simon,
Lead Independent Director -
Kevin O'Boyle,
Independent Director -
Caroline Van Hove,
Independent Director -
R Scott Greer,
Director -
Matthew Pigeon,
CFO and Treasurer -
Hani M Zeini,
Director -
Advisors Llc Orbi Med Capit...,
-
Alexander W. Casdin,
Director -
Charles Huiner,
COO & SVP Corp. Dev. Strategy -
Patrick F. Williams,
General Manager miraDry & SVP -
Llp Abingworth,
10% owner -
Timothy Haines,
Director -
Oliver Christian Bennett,
GC & Chief Compliance Officer -
Valerie J Miller,
VP, Controller and Interim CFO -
Nori Ebersole,
Director -
Andrew C Schmidt,
Chief Financial Officer -
Irina Erenburg,
Director -
Ronald Menezes,
President and CEO